Di Carlo V - Search Results

1

The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, Piemonti L. Monti P, et al. Among authors: di carlo v. Cancer Res. 2003 Nov 1;63(21):7451-61. Cancer Res. 2003. PMID: 14612545

2

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.

Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F. Piemonti L, et al. Among authors: di carlo v. Diabetes. 2002 Jan;51(1):55-65. doi: 10.2337/diabetes.51.1.55. Diabetes. 2002. PMID: 11756323

3

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Monti P, Marchesi F, Reni M, Mercalli A, Sordi V, Zerbi A, Balzano G, Di Carlo V, Allavena P, Piemonti L. Monti P, et al. Among authors: di carlo v. Virchows Arch. 2004 Sep;445(3):236-47. doi: 10.1007/s00428-004-1053-x. Epub 2004 Jul 17. Virchows Arch. 2004. PMID: 15258755

4

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.

Marchesi F, Piemonti L, Fedele G, Destro A, Roncalli M, Albarello L, Doglioni C, Anselmo A, Doni A, Bianchi P, Laghi L, Malesci A, Cervo L, Malosio M, Reni M, Zerbi A, Di Carlo V, Mantovani A, Allavena P. Marchesi F, et al. Among authors: di carlo v. Cancer Res. 2008 Nov 1;68(21):9060-9. doi: 10.1158/0008-5472.CAN-08-1810. Cancer Res. 2008. PMID: 18974152

5

Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells.

Monti P, Allavena P, Di Carlo V, Piemonti L. Monti P, et al. Among authors: di carlo v. Int Immunopharmacol. 2003 Feb;3(2):189-96. doi: 10.1016/s1567-5769(02)00253-9. Int Immunopharmacol. 2003. PMID: 12586600

6

Strategies for tumor immune escape.

Piemonti L, Zerbi A, Di Carlo V. Piemonti L, et al. Among authors: di carlo v. Drugs Today (Barc). 2003 Sep;39(9):701-24. doi: 10.1358/dot.2003.39.9.799478. Drugs Today (Barc). 2003. PMID: 14586485 Review.

7

Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell.

Monti P, Leone BE, Zerbi A, Balzano G, Cainarca S, Sordi V, Pontillo M, Mercalli A, Di Carlo V, Allavena P, Piemonti L. Monti P, et al. Among authors: di carlo v. J Immunol. 2004 Jun 15;172(12):7341-9. doi: 10.4049/jimmunol.172.12.7341. J Immunol. 2004. PMID: 15187110

8

Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release.

Melzi R, Piemonti L, Nano R, Clissi B, Calori G, Antonioli B, Marzorati S, Perseghin G, Di Carlo V, Bertuzzi F. Melzi R, et al. Among authors: di carlo v. Transplantation. 2004 Nov 27;78(10):1564-7. doi: 10.1097/01.tp.0000144184.20085.41. Transplantation. 2004. PMID: 15599324

9

Intraductal papillary mucinous tumors of the pancreas: incidence, clinical findings and natural history.

Balzano G, Zerbi A, Di Carlo V. Balzano G, et al. Among authors: di carlo v. JOP. 2005 Jan 13;6(1 Suppl):108-11. JOP. 2005. PMID: 15650294 No abstract available.

10

Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?

Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V. Zerbi A, et al. Among authors: di carlo v. Ann Surg Oncol. 2008 Apr;15(4):1161-8. doi: 10.1245/s10434-007-9782-0. Epub 2008 Jan 15. Ann Surg Oncol. 2008. PMID: 18196343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters